Middle-age adults who sleep six or fewer hours a night may be at higher risk of developing dementia in later life. People age 50 or 60 who
A study in Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring linked an imbalanced bacterial community in the oral microbiome to a biomarker for Alzheimer’s disease. Researchers
Eli Lilly and Company’s experimental intravenous drug donanemab may slow the cognitive decline of patients with Alzheimer’s disease, according to early clinical trial results, published
Questions currently remain whether the cognitive changes are leading to psychiatric conditions or the psychiatric conditions are contributing to the cognitive changes. Researchers at the
Tau protein has served as an early indicator in detecting Alzheimer’s disease before symptoms develop. However, almost all research to develop this theory has been
Researchers in Canada conducted a retrospective study which discovered living near a busy road may increase changes of developing dementia. The study extrapolated information from
